Lemtrada

As of late 2014, interferon beta injection was the standard "disease-modifying" treatment for patients with relapsing-remitting… (More)

NEW DRUG APPROVALS Blincyto for Rare Form of ALL The FDA has approved blinatumomab (Blincyto, Amgen) to treat patients with… (More)

BACKGROUND Multiple sclerosis (MS) is a common complex disorder, with new treatment options emerging each year. Social media is… (More)

The lymphocyte depleting anti-CD52 monoclonal antibody alemtuzumab has been used in Cambridge, UK, as an experimental treatment… (More)

Although some treatments are now available for multiple sclerosis, better treatments are needed for people with aggressive… (More)

Two long-awaited multiple sclerosis (MS) drugs, Sanofi’s (Genzyme) alemtuzumab (Lemtrada) and Biogen Idec’s BG-12 (dimethyl… (More)

Two long-awaited multiple sclerosis (MS) drugs, Sanofi’s (Genzyme) alemtuzumab (Lemtrada) and Biogen Idec’s BG-12 (dimethyl… (More)

Two clinical trials published in The Lancet have shown that a monoclonal antibody used to treat leukaemia is also an effective… (More)

volume 29 number 4 april 2011 nature biotechnology “The ERT business is the key asset,” says Fernandez. “To have a longer term… (More)

On March 7, the board of directors of Genzyme recommended that shareholders accept a buyout offer from global pharma giant Sanofi… (More)